Comparison of Rice-richen and Wheaten-richen Meal on Glucose Control Among Chinese Women With Gestational Diabetes Melitus (GDM)
Research on Comparison Between Rice-richen Meal and Wheaten-richen Meal on Glucose Control Status Among Chinese Women With GDM
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Since the prevalence of gestational diabetes melitus (GDM) increased by ..., as an important part of medical treatment, nutrition therapy is highly required to help patients achieve normoglycemia. Carbohydrate intake is the primary nutrient affecting postprandial glucose levels,therefore the total amount and type of carbohydrate should be manipulated to blunt postprandial hyperglycemia. However,the type of carbohydrate has not yet been established. Rice and wheaten food have similar Glycemic Index (GI),but some researches found the glucose response to them is different. A case-control study is designed to compare the glucose control status between rice-richen meal and wheaten-richen meal, and all other macronutrients and micronutrients are all calculated and same between two groups, which may provide more clues for type of carbohydrate recommendation for Chinese women with GDM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2018
CompletedFirst Posted
Study publicly available on registry
June 11, 2018
CompletedStudy Start
First participant enrolled
June 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 23, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 23, 2019
CompletedJune 11, 2018
May 1, 2018
5 months
May 29, 2018
May 29, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
between-group difference in glucose control
comparison of the percentage of desired glucose status between two groups
16 weeks
Secondary Outcomes (1)
between-group difference in undesirable clinical outcome
20 weeks
Study Arms (2)
rice-richen meal
OTHERAll participants included in the study will be randomized assigned into one of two groups in parallel, the rice-richen meal group and wheaten-richen meal group. The intervention of group one is that participants will be provided with rice-richen meal, meaning most of the calculated carbohydrates are from rice.
wheaten-richen meal
OTHERAll participants included in the study will be randomized assigned into one of two groups in parallel, the rice-richen meal group and wheaten-richen meal group.The intervention of group two is that participants will be provided with wheaten-richen meal, meaning most of the calculated carbohydrates are from wheaten.
Interventions
Participants in group one will be provided with rice-richen meal. All participants will be required to test and record blood glucose.
Participants in group two will be provided with wheaten-richen meal.All participants will be required to test and record blood glucose.
Eligibility Criteria
You may qualify if:
- Pregnant women who undergo health examination in obstetric department in Peking Union Medical College Hospital.
- years old.
- Pregnant women who are diagnosed with GDM according to the American College of Obstetricians and Gynecologists (ACOG) diagnostic criteria during 24-28 weeks.
- Be ability to use mobile medical equipment, conditional follow-up of the mother and child.
- Voluntary participation in this study.
You may not qualify if:
- Multiple pregnancy.
- Merger of serious diseases (such as hypertension, respiratory diseases, kidney disease, abnormal coagulation, immune system diseases, infectious diseases), history of adverse pregnancy (such as spontaneous abortion, habitual abortion), and history of GDM.
- Pregnant women with known diabetes before pregnancy, those requiring insulin or hormone therapy.
- Pregnant women who are deemed inappropriate to participate in this clinical study by her physician.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Yanping Liu, master
Peking Union Medical College Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
May 29, 2018
First Posted
June 11, 2018
Study Start
June 23, 2018
Primary Completion
November 23, 2018
Study Completion
February 23, 2019
Last Updated
June 11, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share